https://www.selleckchem.com/pr....oducts/glafenine.htm
In some hospitals it is still common practice to carry out a sentinel node biopsy (SN if ductal carcinoma in situ (DCIS) is determined in preoperative staging, although this is against international guidelines. The reason for this is because an infiltrative component can be demonstrated frequently in the final pathohistological examination. In this study, we wanted to investigate possible predictors for infiltrative growth, to select patients to do an SNB or to omit it. All patients with DCIS in the core needle biopsy (CN, who wer
Like
Comment
Share
